TickerFacts.

Universe Pharmaceuticals Inc (UPC): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Figures out of scale. In this company's filings, reported revenue for the year ended 2023-09-30 is more than 100 times total assets. That usually means a value was tagged in the wrong unit. Figures are shown as filed; growth rates are not computed, and the company is left out of screens and comparisons.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-09-30 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$2.40B
Year ended 2025-09-30. As filed; likely tagged in the wrong unit
$14.04M2019-09-30: $10.17M2020-09-30: $10.66M2021-09-30: $14.04M2022-09-30: -$6.49M2023-09-30: -$3.46B2024-09-30: -$7.53B2025-09-30: -$2.40B-$2.40B
2019-09-30 EBITDA (USD) 2025-09-30
Period endedEBITDAChange YoYSource filing
2025-09-30-$2.40Bn/a2026-01-29, From 2024-10-01
2024-09-30-$7.53Bn/a2026-01-29, From 2023-10-01
2023-09-30-$3.46Bn/a2026-01-29, From 2022-10-01
2022-09-30-$6.49Mn/a2025-04-29, From 2021-10-01
2021-09-30$14.04Mn/a2024-01-30, From 2020-10-01
2020-09-30$10.66Mn/a2023-02-10, From 2019-10-01
2019-09-30$10.17Mn/a2022-01-31, From 2018-10-01